Analytica Goes Totally Digital
Analytica 2020 have announced that their 2020 trade fair will be totally digital, due to COVID-19-related restrictions.
The digital format will allow virtual visits to exhibition booths where product presentations and product flyers will be available along with the ability to contact the respective exhibitor directly via a text, audio, and video chat feature.
“We are glad that Messe München has reacted flexibly and quickly and in the form of analytica virtual to offer the proper concept for 2020”, emphasizes Siegbert Holtermüller, Chairman of Analytica’s Exhibitor Advisory Board.
The virtual trade fair will be open 24 hours a day from October 19 to 23, 2020. Product novelties and product innovations from all fields of laboratory and analytical technology for the target industries of chemistry, biotech, pharmaceuticals, and foodstuffs will be presented. In addition, webinars and parts of the classic Analytica supporting programme are to be made available via the platform. Important events will be repeated at different times of the day to reach interested parties in distant time zones. One of Analytica’s highlights, the special show Digital Transformation, will be present both in Munich and at Analytica Virtual. The show illustrates the state of laboratory automation in a presentation that is unique in the world.
Exhibitors and visitors can now register for Analytica Virtual. For further information, please go to: www.analytica.de
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
